UBS O'Connor’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

UBS O'Connor’s Portfolio SHACW Stock Details SHACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-789,689	Closed	-$38K	–	838
2022 Q3	$38K	Sell	789,689 -82,773	-9%	-$4.12K	﹤0.01%	865
2022 Q2	$74K	Buy	+872,462	New	+$122K	﹤0.01%	862
2022 Q1	–	Sell	-866,222	Closed	-$477K	–	705
2021 Q4	$477K	Hold	866,222	–	–	﹤0.01%	684
2021 Q3	$478K	Hold	866,222	–	–	﹤0.01%	646
2021 Q2	$702K	Hold	866,222	–	–	0.01%	589
2021 Q1	$526K	Buy	+866,222	New	+$532K	0.01%	600

UBS O'Connor's SHACW Position: Q4 2022 in Review

UBS O'Connor sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 789,689 shares — an estimated $38K sold.

UBS O'Connor first reported a position in SHACW in Q1 2021 and held it in 6 quarters. The position peaked at $702K in Q2 2021. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

UBS O'Connor reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 789,689 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $38K.
UBS O'Connor first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 6 quarters.
UBS O'Connor's SCP & CO Healthcare Acquisition Company Warrant position peaked at $702K in Q2 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.